High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency
- 1 August 2007
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 124 (2) , 182-189
- https://doi.org/10.1016/j.clim.2007.04.012
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF productionAnnals of the Rheumatic Diseases, 2007
- Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRILBlood, 2006
- Role of BAFF and APRIL in human B‐cell chronic lymphocytic leukaemiaImmunology, 2006
- B-Cell-Targeted Therapy for Systemic Lupus ErythematosusDrugs, 2006
- Common variable immunodeficiency presenting with a large abdominal massJournal of Allergy and Clinical Immunology, 2005
- BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosusArthritis & Rheumatism, 2005
- Normal B Cell Homeostasis Requires B Cell Activation Factor Production by Radiation-resistant CellsThe Journal of Experimental Medicine, 2003
- BAFF: A fundamental survival factor for B cellsNature Reviews Immunology, 2002
- Hematologic complications of primary immune deficienciesBlood Reviews, 2002
- Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseasesArthritis & Rheumatism, 2001